BioFLO for Respiratory Recovery in SCI - Trial NCT06011876
Access comprehensive clinical trial information for NCT06011876 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Florida and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 62 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Florida
Timeline & Enrollment
N/A
Dec 01, 2023
Sep 01, 2027
Primary Outcome
Change in motor evoked potential,Change in maximal inspiratory pressure,Change in maximal expiratory pressure
Summary
Acute intermittent hypoxia (AIH) involves brief (1 min), repeated episodes (~15) of breathing
 low oxygen air to stimulate spinal neuroplasticity. Animal and human studies show that AIH
 improves motor function after spinal cord injury, particularly with slightly increased carbon
 dioxide (hypercapnic AIH; AIHH) and task-specific training. Using a double blind cross-over
 design, the study will test whether AIHH improves breathing more than AIH and whether
 specific genetic variations are related to individuals' intervention responses.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06011876
Non-Device Trial